Wallington Asset Management LLC Cuts Holdings in Roche Holding AG (OTCMKTS:RHHBY)

Wallington Asset Management LLC lessened its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY) by 2.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 45,157 shares of the company’s stock after selling 1,300 shares during the period. Wallington Asset Management LLC’s holdings in Roche were worth $1,575,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Kornitzer Capital Management Inc. KS increased its position in shares of Roche by 1.3% in the third quarter. Kornitzer Capital Management Inc. KS now owns 136,923 shares of the company’s stock valued at $5,490,000 after buying an additional 1,798 shares in the last quarter. Bard Financial Services Inc. increased its holdings in Roche by 37.7% during the 4th quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock valued at $3,866,000 after acquiring an additional 30,350 shares in the last quarter. Diversified Trust Co raised its position in Roche by 1.2% during the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after acquiring an additional 711 shares during the last quarter. Norman Fields Gottscho Capital Management LLC lifted its holdings in shares of Roche by 5.5% in the third quarter. Norman Fields Gottscho Capital Management LLC now owns 26,000 shares of the company’s stock valued at $1,039,000 after purchasing an additional 1,350 shares in the last quarter. Finally, Confluence Investment Management LLC grew its position in shares of Roche by 26.3% in the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock valued at $488,000 after purchasing an additional 2,910 shares during the last quarter.

Roche Stock Down 0.9 %

RHHBY stock opened at $36.35 on Friday. The stock’s 50 day moving average price is $35.79 and its 200 day moving average price is $38.00. Roche Holding AG has a 1 year low of $29.20 and a 1 year high of $42.43.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.